Published in Women's Health Weekly, November 4th, 2004
According to Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), the ACOG report adds to the evidence-based consensus among leading women's health experts regarding the important role of estrogen and estrogen plus progestin (as hormone therapy, or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly